Bright Minds Biosciences ... (DRUG)
undefined
undefined%
At close: undefined
41.45
0.61%
After-hours Dec 13, 2024, 04:16 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 72.45K 6.04K - - -
Gross Profit -72.45K -6.04K - - -
Operating Income -7.21M -14.74M -8.76M -469.36K -78.72K
Interest Income - - - - -
Pretax Income -7.37M -14.96M -8.65M -480.38K -78.72K
Net Income -7.37M -15.19M -8.52M -485.94K -78.72K
Selling & General & Admin 2.21M 2.55M 2.29M 114.51K 36.71K
Research & Development 5.00M 12.18M 6.31M 354.85K 42.01K
Other Expenses - -243.08K -181.74K -5.45K -
Operating Expenses 7.21M 14.73M 8.60M 469.36K 78.72K
Interest Expense 19.75K 222.78K - - -
Selling & Marketing Expenses 119.42K 551.86K 852.15K 9.62K 36.60K
Cost & Expenses 7.21M 14.73M 8.60M 469.36K 78.72K
Income Tax - 222.78K -135.43K 5.57K -236.15
Shares Outstanding (Basic) 3.72M 2.47M 1.79M 1.28M 1.28M
Shares Outstanding (Diluted) 3.72M 2.47M 1.79M 1.28M 1.28M
EPS (Basic) -1.98 -6.15 -4.74 -0.38 -0.06
EPS (Diluted) -1.98 -6.15 -4.74 -0.38 -0.06
EBITDA -7.28M -14.96M - - -
Depreciation & Amortization 72.45K 6.04K 8.62M 474.93K 236.15K